Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Wilms Tumor 1Sarcoma 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Kidney Neoplasms 1Hematologic Neoplasms 1Fanconi Anemia 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Squamous Cell 1Burkitt Lymphoma 1Body Weight 1

Interventions

fludarabine phosphate 3Antilymphocyte Serum 3Cyclophosphamide 2AP 1903 reagent 2thymoglobulin 1sargramostim 1prexasertib 1fludarabine 1Whole-Body Irradiation 1Tacrolimus 1SRA737 1Quercetin 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dietary Supplements 1Cord Blood Stem Cell Transplantation 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Fanconi Anemia × Dietary Supplements × Clear all
NCT03476330 2026-04-20

Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
48 enrolled 7 charts
Classical hematology

Carcinoma, Squamous Cell, Fanconi Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡